A drop in mortgage rates has failed to ignite home-buying demand, but builders remain optimistic
The numbers: Builder confidence rose in October as they expect mortgage rates to fall and U.S. home-buying conditions to ...
The world isn’t prepared for an aging population — but it’s actually a huge opportunity
The global population is aging, and no country, company or government is fully prepared to handle, and potentially benefit ...
Nvidia’s stock tracks toward record as TSMC sees AI chip market still booming
All members of the PHLX Semiconductor Index were in positive territory Thursday as TSMC offered upbeat commentary on the ...
Yields, euro lower as Lagarde wraps up conference
The press conference ends, with the euro and bond yields a bit weaker than where they began. While saying in response to ...
Dow opens higher, semiconductors rebound after strong TSMC earnings
U.S. stocks opened higher on Thursday as strong earnings from Taiwan Semiconductor Manufacturing Company helped boost chips ...
Gold futures top $2,700 an ounce, on track to settle at a record high
Gold futures climbed above $2,700 an ounce on Thursday, with prices based on the most-active contract poised to settle at a fresh record high. "Uncertainty surrounding the U.S. economic outlook contin ...
S&P 500 briefly heads for record close
The S&P 500 was on pace for back-to-back gains on Thursday, and briefly was on pace for another record close. The equity gauge was last trading 0.2% higher, at around 5,851, according to FactSet. It ...
Canada Watchdog Anticipates C$46 Billion Budget Deficits, Above Liberal Government's Promise -- Update
In an updated economic and fiscal outlook, Canada's Office of the Parliamentary Budget Officer said it expects the country's Department of Finance to report a budget deficit for the 2023-24 fiscal ...
Industrial production falls in September
Industrial production fell 0.3% in September, although the decline was driven by a strike at Boeing and the effects of two hurricanes, according to the l ...
Avadel Gets Expanded FDA OK of Lumryz for Use in Children
Avadel Pharmaceuticals has won expanded Food and Drug Administration approval of its narcolepsy drug Lumryz for use in children. Avadel on Thursday said the FDA nod covers Lumryz for the treatment of ...
Sage Therapeutics Cutting Workforce by 33% -- Update
Sage and Biogen last year won Food and Drug Administration approval of Zurzuvae as the first pill to treat postpartum depression, but the agency rejected the drug for major depressive disorder, a much ...
Economist sees room for doubt about Fed cutting rates again in November
Surprisingly strong retail-sales data released Thursday could dim the odds of a Federal Reserve rate cut at the central bank's November meeting, according to Nationwide chief economist Kathy ...